Yen‐Hou Chang — Endo Lab

2023

MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.

Cancer research ·doi:10.1158/0008-5472.can-22-1159

Epithelial ovarian cancer is a highly heterogeneous and malignant female cancer with an overall low survival rate. Mutations in p53 are prevalent in the major ovarian cancer histotype, high-grade serous ovarian carcinoma (HGSOC), while p53 …

article 2022

Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study

International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14635

OBJECTIVE: To investigate the safety and efficacy of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) treatment followed by maintenance dienogest (DNG) therapy after uterus-sparing surgery. METHODS: Retrospective cohort study. A to…

article 2022

Maintenance Therapy for Preventing Endometrioma Recurrence After Endometriosis Resection Surgery—A Systematic Review and Network Meta-analysis

·doi:10.1097/ogx.0000000000001045

(Abstracted from J Minim Invasive Gynecol 2022;29:602–612) Endometriosis is one of the most common gynecologic disorders, affecting approximately 10% of reproductive-age women and presenting with dysmenorrhea, noncyclic pelvic pain, dyspare…